Cytosar

Cytosar Warnings and Precautions

• Bone marrow suppression: Cytosar is a potent bone marrow suppressant. Blood counts should be monitored closely, especially in patients with pre-existing suppression.
• Cytarabine syndrome: Fever, muscle and bone pain, rash, and conjunctivitis can occur 6-12 hours after administration. Corticosteroids may help prevent or treat this reaction.
• Neurotoxicity (with high-dose regimens): Cerebellar effects such as unsteady gait, slurred speech, and abnormal eye movements can occur, along with rarer confusion or seizures.
• Ocular toxicity: Corneal irritation and conjunctivitis can occur, especially with high-dose regimens; preventive corticosteroid eye drops may be used.
• Pulmonary toxicity: Sudden respiratory distress has been reported, particularly with high-dose therapy.

How to Access Cytosar in India: A 6-Step Process

Step 1 – Search & request your medicine: The patient or treating doctor submits a request with basic details to initiate the access process.

Step 2 – Verification & eligibility review: The team verifies availability and reviews eligibility against regulatory and clinical requirements to ensure a compliant pathway.

Step 3 – Receive quote & delivery timeline: A transparent quotation is shared, covering medicine cost, logistics, and a clear delivery timeline.

Step 4 – Regulatory approval process: Assistance is provided to secure the approvals and documentation required for legal cross-border access.

Step 5 – Temperature-controlled import & handling: The medicine is sourced and transported under strict GDP-compliant conditions to maintain product integrity.

Step 6 – Secure delivery: The medicine is delivered to the patient or treating hospital, with updates provided at each stage.

Note: From request to delivery, every step is designed to ensure your treatment reaches you safely, compliantly, and without unnecessary delays.

Documentation & Availability

What documents are required to import Cytosar to India?

Cytosar (cytarabine) injection may be imported in the patient's name only, by patients or government hospitals, in line with India's import regulations for unapproved medicines. The following documentation is required:

• A valid prescription from a qualified doctor
• The patient's diagnostic reports and treatment plan
• Patient ID proof (issued by the Government of India)

How is the order confirmed?

The order is confirmed only after receipt and verification of a valid prescription from the doctor and, if applicable, an import permit.

Is Cytosar available in India?

Cytosar (cytarabine injection) is a prescription medicine that legally requires a doctor's prescription to be dispensed. As of current publicly available information, Cytosar is not commercially marketed in India under this brand.

However, patients in India can legally access Cytosar through the Named Patient Program (NPP) — an import provision that allows a medicine not yet registered in India to be imported in the name of a specific patient for their personal treatment, under a valid prescription.

Cytarabine has been FDA approved for decades, ensuring full transparency throughout the process.

Cytosar can be made available to patients, doctors, and hospitals across major cities in India, including Gurgaon, Delhi, Bangalore, Mumbai, Navi Mumbai, Thane, Hyderabad, Mysore, Kerala, Chennai, Coimbatore, Madurai, Kolkata, Ahmedabad, Surat, Vadodara, Pune, Nagpur, Nashik, Jaipur, Udaipur, Lucknow, Kanpur, Gorakhpur, Chandigarh, Mohali, Faridabad, Noida, Ghaziabad, Kochi, Trivandrum, Kozhikode, Thrissur, Kannur, Mangalore, Bhubaneswar, Patna, Ranchi, Raipur, Guwahati, Visakhapatnam, Vijayawada, Goa, Jammu, Srinagar, Dehradun, Bhopal, Indore, Ludhiana, Amritsar, and others — and can facilitate delivery to the patient's treating hospital. Orders are confirmed only after receipt of a valid doctor's prescription and an import permit, where applicable.

Sourcing & Delivery

NamedPatientProgram.com (NPP) can source Cytosar from reliable global channels and facilitate supply to patients, doctors, and hospitals under applicable legal provisions. Cytosar vials should be stored at 15°C to 30°C; once reconstituted, the manufacturer recommends use within 48 hours. Handling follows temperature-controlled shipping conditions throughout transit. All prescriptions are dispensed and checked by registered pharmacists and dispatched from New Delhi, India, after legal requirements are fulfilled.

For Cytosar cost in India and availability, contact NPP via WhatsApp at +91 98104 69557 | Toll-Free: 1800-1200-365 or email info@namedpatientprogram.com.

Availability of Cytosar Across Major Cities in India

Patients across India can access Cytosar through regulated import pathways, with delivery arranged to the treating hospital based on a valid oncologist's prescription.

Mumbai

A major oncology hub with institutions like Tata Memorial, Mumbai coordinates access to chemotherapy agents like Cytosar for eligible patients.

Delhi

As part of the Delhi NCR region, the city has a strong concentration of cancer centers, making it a key location for accessing leukemia treatments.

Bangalore

With a growing network of multispecialty oncology hospitals, Bangalore supports access to Cytosar through structured import pathways guided by treating specialists.

Chennai

Home to several reputed cancer treatment centers, Chennai facilitates access to Cytosar for patients undergoing leukemia chemotherapy.

Hyderabad

A growing hub for oncology care, Hyderabad supports coordinated access to Cytosar for eligible patients under specialist supervision.

Kolkata

Eastern India's leading cancer centers in Kolkata coordinate Cytosar access for patients undergoing leukemia treatment.

Pune

With an expanding base of oncology clinics, Pune facilitates timely access to Cytosar under prescription.

Ahmedabad

Gujarat's leading cancer hospitals support regulated access to Cytosar for eligible patients.

Kochi

Kerala's healthcare network, including major cancer centers in Kochi, coordinates access to chemotherapy agents like Cytosar.

Chandigarh

Serving North India, Chandigarh's oncology centers facilitate access to Cytosar for patients from Punjab, Haryana, and Himachal Pradesh.

Jaipur

Rajasthan's leading hospitals support patient access to Cytosar through the Named Patient Program.

Lucknow

A key referral center for North India, Lucknow facilitates coordinated access to Cytosar under oncologist care.

Bhubaneswar

Odisha's growing oncology sector supports patient access to Cytosar.

Guwahati

As a referral hub for the North-East, Guwahati facilitates access to Cytosar for patients across the region.

Access can also be coordinated for patients in other major Indian cities, subject to a valid prescription and regulatory requirements.